FBTAX Mutual Fund

FBTAX Mutual Fund (Fidelity Advisor Biotechnology Fund Class A) is managed by Fidelity Investments (US) with $928.8M in net assets. FBTAX expense ratio is 0.94%, holding 131 positions across sectors including Health Care, Financials, Industrials. Inception date: 2000-12-27.

FBTAX performance shows a YTD return of 29.33%. The 1-year return is 35.40% and the 5-year return is 13.00%. FBTAX dividend yield stands at 0.93%, paid annually.

FBTAX top holdings include Abbvie Inc. (13.8%), Gilead Sciences (6.0%), Alnylam Pharmaceuticals Inc. (3.8%), Insmed Inc (3.4%), Amylyx Pharmaceuticals Inc (3.4%). Go to all FBTAX holdings, FBTAX sectors, or FBTAX dividends.

FBTAX can be compared against other funds. Use FBTAX overlap to find shared positions, or FBTAX vs another fund for a side-by-side view. FBTAX alternatives are available via the screener, along with tax-loss harvesting opportunities.